GSK is a fully focused biopharma company. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics, genomics and advanced technologies, and our world-leading capabilities in vaccines and medicines development.
We focus on four therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.
Our Long-term Priorities
We’re uniting science, technology and talent to make a difference in more people’s lives. We don’t just want to find new, better medicines and vaccines. We’re working to get better at finding them in ways that are faster, more effective, and more predictable. This is reflected in the continued success of our R&D pipeline, which saw significant progress in 2022. Strategic partnerships are critical to opening up new avenues of discovery. We have important collaborations, including with the University of Oxford on neurodegenerative diseases, Kings College London on cancer treatment and 23andMe on genetics and genomics.
We’re confident in our future. Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery by 2026. This means more GSK vaccines and medicines, including innovative new products, will reach more people who need them than ever before.
Being a responsible business means getting ahead of disease together in the right way. We therefore need to consider ESG impact across everything we do, from the lab to the patient. We have identified six ESG focus areas that address what is most material to our business and the issues that matter to our stakeholders. These focus areas are access to healthcare, global health and health security, environment, diversity, equity and inclusion, ethical standards, product governance.
Culture at GSK is something we all own. It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. Our culture of being ambitious for patients, accountable for impact and doing the right thing are the foundations for how, together, we’ll deliver for our patients, shareholders and GSK people.
Our Code sets out the commitments GSK and our people make to get ahead together – so we can deliver on our ambition in the right way, bring our culture to life and make GSK an exciting and inspiring place to work.
“We recognise that our people are the differentiator in achieving success, and at GSK, we pride ourselves in providing the personal and collective development that is needed to be successful at work. We value the expertise that many HM Forces, Police and Civil Servants can bring to GSK, such as knowledge, experience and diversity of thinking. This has encouraged us to recruit former Service personnel as part of our recruitment strategy. GSK has many roles suited to former Service personnel where they are able to bring transferable skills into the workplace. Areas such as the Supply Chain, Manufacturing, Logistics and Distribution, Security and Investigations, Personnel and General Management all have characteristics that would have been similar in the Services, be that proven leadership and decision making, a disciplined approach, technical skills and expertise, adaptability and agility, and the ability to focus and prioritise on the most important issues.”
Veteran - Adam Mallalieu, Vice President, Head of Corporate Security & Investigations